HK1044286A1 - Solid preparation containing chitosan powder and process for producing the same - Google Patents

Solid preparation containing chitosan powder and process for producing the same

Info

Publication number
HK1044286A1
HK1044286A1 HK02105868A HK02105868A HK1044286A1 HK 1044286 A1 HK1044286 A1 HK 1044286A1 HK 02105868 A HK02105868 A HK 02105868A HK 02105868 A HK02105868 A HK 02105868A HK 1044286 A1 HK1044286 A1 HK 1044286A1
Authority
HK
Hong Kong
Prior art keywords
medicament
chitosan powder
preparation containing
solid preparation
large intestine
Prior art date
Application number
HK02105868A
Other languages
English (en)
Inventor
Norihito Shimono
Masaaki Mori
Yutaka Higashi
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of HK1044286A1 publication Critical patent/HK1044286A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK02105868A 1999-08-09 2002-08-12 Solid preparation containing chitosan powder and process for producing the same HK1044286A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22477799 1999-08-09
PCT/JP2000/005279 WO2001010467A1 (fr) 1999-08-09 2000-08-07 Preparations solides contenant de la poudre de chitosane et procede de production associe

Publications (1)

Publication Number Publication Date
HK1044286A1 true HK1044286A1 (en) 2002-10-18

Family

ID=16819059

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105868A HK1044286A1 (en) 1999-08-09 2002-08-12 Solid preparation containing chitosan powder and process for producing the same

Country Status (12)

Country Link
US (1) US7604820B1 (de)
EP (1) EP1203590B1 (de)
JP (1) JP4659316B2 (de)
KR (1) KR20020015721A (de)
CN (1) CN1162183C (de)
AT (1) ATE366119T1 (de)
AU (1) AU778049B2 (de)
CA (1) CA2378265C (de)
DE (1) DE60035421T2 (de)
ES (1) ES2288152T3 (de)
HK (1) HK1044286A1 (de)
WO (1) WO2001010467A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
WO2005030173A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Colon-specific drug delivery using interpolymer complexations
DE102004059792A1 (de) 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
JP5386176B2 (ja) * 2006-12-21 2014-01-15 フロイント産業株式会社 キトサン溶液及び該溶液から形成されたキトサンコーティング製剤
JP2009191036A (ja) * 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
EP2371356B1 (de) * 2010-03-12 2012-12-19 Phoeme GmbH Pharmazeutische Mehrfachpartikelformulierung zur Kolonabsorption
JP5087167B2 (ja) * 2010-12-28 2012-11-28 フロイント産業株式会社 ビフィズス菌大腸デリバリーカプセル及びその製造方法
US10799460B2 (en) * 2011-09-07 2020-10-13 Roland SAUR-BROSCH Formulation for the controlled release of one or several substances in the digestive tract of a mammal
EP2765998A1 (de) 2011-10-11 2014-08-20 Ranbaxy Laboratories Limited Gastroretentives dosiersystem und verfahren zu seiner herstellung
JP5102401B1 (ja) 2012-03-30 2012-12-19 森下仁丹株式会社 大腸特異崩壊性カプセル
JP6062802B2 (ja) * 2012-08-23 2017-01-18 日清ファルマ株式会社 キトサン含有組成物及びキトサンコーティング組成物
WO2014097664A1 (ja) * 2012-12-21 2014-06-26 日清ファルマ株式会社 大腸送達カプセル及びその製造方法
CN115192537B (zh) * 2022-07-27 2024-03-26 康普药业股份有限公司 一种甲磺酸萘莫司他组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
JPH064531B2 (ja) * 1990-06-04 1994-01-19 アイセロ化学株式会社 大腸崩壊性硬質カプセル
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
CA2049524A1 (en) 1990-08-30 1992-03-01 Jakob Silbiger Compositions comprising a hydrophillic polymer and a hydrophillic material different therefrom
JP3181062B2 (ja) 1991-01-31 2001-07-03 帝國製薬株式会社 下部消化管崩壊経口製剤
JP3282832B2 (ja) 1991-02-19 2002-05-20 帝國製薬株式会社 持続性錠剤
JP3122478B2 (ja) 1991-02-19 2001-01-09 帝國製薬株式会社 下部消化管放出型経口製剤
JP3592723B2 (ja) 1991-02-19 2004-11-24 帝國製薬株式会社 非崩壊・持続性カプセル製剤
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JP2521229B2 (ja) 1993-06-17 1996-08-07 アイセロ化学株式会社 大腸崩壊性組成物及びその製造法
DE69528583T2 (de) 1994-04-22 2003-07-10 Yamanouchi Pharmaceutical Co., Ltd. Kolon-spezifisches arzneistofffreisetzungssystem
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
DK1021171T3 (da) 1997-10-09 2003-08-25 Dexcel Pharma Technologies Ltd Lægemiddelfremførelsessystem til forsinket, fuldstændig frigivelse gastrointestinalt
US6197322B1 (en) * 1997-12-23 2001-03-06 Kimberly-Clark Worldwide, Inc. Antimicrobial structures

Also Published As

Publication number Publication date
AU778049B2 (en) 2004-11-11
ATE366119T1 (de) 2007-07-15
AU6472300A (en) 2001-03-05
CN1162183C (zh) 2004-08-18
DE60035421T2 (de) 2008-03-13
CN1377281A (zh) 2002-10-30
EP1203590B1 (de) 2007-07-04
CA2378265C (en) 2007-11-20
WO2001010467A1 (fr) 2001-02-15
KR20020015721A (ko) 2002-02-28
CA2378265A1 (en) 2001-02-15
EP1203590A1 (de) 2002-05-08
ES2288152T3 (es) 2008-01-01
JP4659316B2 (ja) 2011-03-30
EP1203590A4 (de) 2005-01-19
DE60035421D1 (de) 2007-08-16
US7604820B1 (en) 2009-10-20

Similar Documents

Publication Publication Date Title
HK1044286A1 (en) Solid preparation containing chitosan powder and process for producing the same
DK0820300T3 (da) Biologisk nedbrydelige nanopartikler med kontrolleret frigivelse indeholdende insulin
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
ATE213936T1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
EP0761212A3 (de) Brausemittel und dessen Herstellung
MX9704910A (es) Formula de liberacion controlada (albuterol).
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
EP2033648A3 (de) System zur Verabreichung von Prodrug-haltigen Arzneimitteln mit verzögerter Freisetzung
BG102228A (en) Medicamentous form with controlled release of slightly soluble medicamentous substances
CA2106952A1 (en) A single dose vaccination system
AU4800999A (en) Preparation capable of releasing drug at target site in intestine
DE69915184D1 (de) Pharmazeutische Formulierung und Dosierform bestehend aus Polysacchariden zur kontrollierten Wirkstoff-Freisetzung im Dickdarm
AU2001276733A1 (en) Lactic acid polymer and process for producing the same
AU2003212518A1 (en) Medicament delivery and packaging
EP0871435A4 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
CA2342309A1 (en) New solid dose form of nanoparticulate naproxen
WO1996021415A3 (en) Alteration of nutritional product during enteral tube feeding
WO1995001782A3 (en) Method for making freeze dried drug dosage forms
BG104253A (en) Perforated microparticles and method for their utilization
HUT53813A (en) Coating material controlling release of medicaments
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
AU6251094A (en) Bisacodyl dosage form
EP1138333A4 (de) Arzneimittel zur oralen verabreichung
MXPA04004631A (es) Aparato en aerosol que comprende cuerpo conectable y pieza de extremo.
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130807